|

1.

[Decrease in heart rate in patients with coronary artery disease and chronic heart failure the purpose and means].

Glezer, M G; Chesnikova, A I; Giliarevskii, S R; Perepech, N B; Astashkin, E I; Lopatin, Iu M; Vasiuk, Iu A.

Kardiologiia ; 54(4): 109-20, 2014.

Article Ru | MEDLINE | ID: mdl-25177793

Cardiovascular Agents/pharmacology , Coronary Artery Disease , Heart Failure , Heart Rate/drug effects , Coronary Artery Disease/complications , Coronary Artery Disease/drug therapy , Coronary Artery Disease/physiopathology , Disease Management , Drug Therapy, Combination , Health Services Needs and Demand , Heart Failure/complications , Heart Failure/drug therapy , Heart Failure/physiopathology , Humans , Patient Care Team/organization & administration , Russia

2.

[The role of alternative approaches to antiischemic therapy in patients with stable coronary artery disease].

Giliarevskii, S R; Rezvan, V V; Kuz'mina, I M; Golshmid, M V.

Kardiologiia ; 53(11): 84-9, 2013.

Article Ru | MEDLINE | ID: mdl-24654440

Contemporary approach to antianginal therapy in patients with stable are reviewed. Benefits and limitations of "standard" antiischemic therapy and evidence-based data about alternative therapy with nicorandil are discussed in details.

Coronary Artery Disease/drug therapy , Nicorandil/therapeutic use , Practice Guidelines as Topic , Vasodilator Agents/therapeutic use , Humans , Treatment Outcome

3.

[Made in Russia system for facilitated external counterpulsation: development and first experience of clinical application].

Khubutiia, A Sh; Sudarev, A M; Tolpekin, V E; Kilasev, N B; Giliarevskii, S R.

Kardiologiia ; 52(3): 91-4, 2012.

Article Ru | MEDLINE | ID: mdl-22839449

Collateral Circulation , Counterpulsation , Myocardial Ischemia , Neovascularization, Physiologic , Aged, 80 and over , Coronary Circulation , Coronary Vessels/physiopathology , Counterpulsation/instrumentation , Counterpulsation/methods , Counterpulsation/trends , Heart-Assist Devices/trends , Humans , Male , Middle Aged , Myocardial Ischemia/physiopathology , Myocardial Ischemia/therapy , Russia , Severity of Illness Index , Treatment Outcome

4.

[Consensus of experts on the role of ethyl esters of omega-3 polyunsaturated fatty acids for the treatment and prevention of chronic heart failure (conclusion of experts meeting, June 2011)].

Belenkov, Iu N; Mareev, V Iu; Arutiunov, G P; Shliakhto, E V; Koziolova, N A; Ageev, F T; Tatarskii, B A; Lopatin, Iu M; Fomin, I V; Kastanian, A A; Ardashev, A V; Giliarevskii, S R; Moiseev, S V; Doshitsin, V L; Linchak, R M.

Kardiologiia ; 51(9): 89-91, 2011.

Article Ru | MEDLINE | ID: mdl-21943014

Fatty Acids, Omega-3 , Heart Failure , Medication Therapy Management , Cardiotonic Agents/administration & dosage , Cardiotonic Agents/pharmacology , Chronic Disease , Exercise Tolerance/drug effects , Fatty Acids, Omega-3/administration & dosage , Fatty Acids, Omega-3/adverse effects , Fatty Acids, Omega-3/pharmacology , Heart Failure/drug therapy , Heart Failure/mortality , Heart Failure/physiopathology , Heart Rate/drug effects , Hemodynamics/drug effects , Humans , Mortality , Myocardial Contraction/drug effects , Treatment Outcome

5.

[Modern approaches to the treatment of patients with acute pronounced elevation of arterial pressure and hypertensive crises].

Giliarevskii, S R; Kuz'mina, I M.

Kardiologiia ; 50(9): 71-90, 2010.

Article Ru | MEDLINE | ID: mdl-21118170

Antihypertensive Agents , Blood Pressure/drug effects , Emergency Treatment , Hypertension, Malignant , Pre-Eclampsia/therapy , Acute Disease , Antihypertensive Agents/administration & dosage , Antihypertensive Agents/adverse effects , Blood Pressure Determination/methods , Blood Pressure Determination/standards , Emergency Treatment/classification , Emergency Treatment/methods , Emergency Treatment/standards , Female , Humans , Hypertension, Malignant/complications , Hypertension, Malignant/epidemiology , Hypertension, Malignant/physiopathology , Hypertension, Malignant/therapy , Hypertensive Encephalopathy/etiology , Hypertensive Encephalopathy/physiopathology , Hypertensive Encephalopathy/prevention & control , Intracranial Hemorrhage, Hypertensive/etiology , Intracranial Hemorrhage, Hypertensive/physiopathology , Intracranial Hemorrhage, Hypertensive/prevention & control , Male , Patient Education as Topic , Pre-Eclampsia/etiology , Pre-Eclampsia/physiopathology , Pregnancy , Preventive Medicine/methods , Russia/epidemiology , Secondary Prevention/education , Secondary Prevention/organization & administration , Treatment Outcome

6.

[Three lives of captopril in the era of evidence based medicine].

Giliarevskii, S R.

Kardiologiia ; 47(1): 82-90, 2007.

Article En | MEDLINE | ID: mdl-17431966

Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Captopril/therapeutic use , Cardiovascular Diseases/drug therapy , Evidence-Based Medicine/methods , Humans , Randomized Controlled Trials as Topic , Treatment Outcome

7.

[Practical approaches to selection of beta-adrenoblocker for the treatment of cardiovascular diseases: novel evidence based data].

Giliarevskii, S R.

Kardiologiia ; 46(11): 79-85, 2006.

Article Ru | MEDLINE | ID: mdl-17183752

Adrenergic beta-Antagonists/therapeutic use , Cardiovascular Diseases/drug therapy , Evidence-Based Medicine/methods , Humans , Treatment Outcome

8.

[Clinical use of acetasolamid in the treatment of cardiovascular diseases].

Giliarevskii, S R.

Voen Med Zh ; 327(4): 23-8, 2006 Apr.

Article Ru | MEDLINE | ID: mdl-16784102

Acetazolamide , Carbonic Anhydrase Inhibitors , Cardiovascular Diseases/drug therapy , Acetazolamide/adverse effects , Acetazolamide/pharmacology , Acetazolamide/therapeutic use , Carbonic Anhydrase Inhibitors/adverse effects , Carbonic Anhydrase Inhibitors/pharmacology , Carbonic Anhydrase Inhibitors/therapeutic use , Clinical Trials as Topic , Humans , Treatment Outcome

9.

[Practical prevention and treatment of cardiovascular diseases in patients with diabetes mellitus type 2 in an endocrinological department]. / Prakticheskaia realizatsiia profilaktiki i lecheniia serdechno-sosudistykh zabolevanii u bol'nykh sakharnym diabetom tipa 2 v usloviiakh éndokrinologicheskogo otdeleniia.

Daurbekova, L V; Orlov, V A; Giliarevskii, S R; Abirova, E S; Murzabekova, L I.

Ter Arkh ; 76(12): 32-6, 2004.

Article Ru | MEDLINE | ID: mdl-15724922

AIM: To analyse retrospectively quality of medical correction of modified risk factors (RF) and treatment of cardiovascular diseases (CVD) in patients with diabetes mellitus type (DM) 2 admitted to specialized endocrinological departments. MATERIAL AND METHODS: Analysis of medication policy of CVD RF was made retrospectively for 250 patients treated in endocrinological departments of Moscow hospital in 2003. RESULTS: Arterial hypertension, coronary heart disease were diagnosed in 93.2 and 87.2% examinees. History of myocardial infarction and brain stroke was in 8.4 and 6% patients. Statins were prescribed in 2.4% cases. Examination for dyslipidemia was not satisfactory. ACE inhibitors were prescribed in 71.2% patients. Aspirin was prescribed (18%) primarily by the cardiologist. CONCLUSION: Quality of medical prophylaxis of CVD RF in DM type 2 patients in the departments does not satisfy modern clinical recommendations.

Angiotensin-Converting Enzyme Inhibitors/administration & dosage , Aspirin/administration & dosage , Cardiovascular Diseases/prevention & control , Diabetes Mellitus, Type 2 , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Platelet Aggregation Inhibitors/administration & dosage , Cardiovascular Diseases/complications , Diabetes Mellitus, Type 2/complications , Endocrinology , Hospital Departments , Humans

10.

[Syndrome of non-thyroid pathology in patients with cardiovascular diseases (review)]. / Sindrom netireoidnoi patologii u bol'nykh s serdechno-sosudistymi zabolevaniiami (obzor).

Ametov, A S; Balashova, N V; Giliarevskii, S R.

Ter Arkh ; 75(10): 25-30, 2003.

Article Ru | MEDLINE | ID: mdl-14669601

Cardiovascular Diseases/complications , Euthyroid Sick Syndromes/etiology , Thyroxine/blood , Triiodothyronine/blood , Anti-Arrhythmia Agents/therapeutic use , Cardiovascular Diseases/blood , Cardiovascular Diseases/drug therapy , Euthyroid Sick Syndromes/blood , Euthyroid Sick Syndromes/drug therapy , Humans , Thyroxine/therapeutic use , Triiodothyronine/therapeutic use

11.

[What determines economic effectiveness of treatment of arterial hypertension]. / Chto opredeliaet ékonomicheskuiu éffektivnost' lecheniia arterial'noi hipertonii?

Ostroumova, O D; Giliarevskii, S R; Mamaev, V I.

Kardiologiia ; 43(12): 86-90, 2003.

Article Ru | MEDLINE | ID: mdl-15035260

Hypertension/economics , Aged , Cost-Benefit Analysis , Female , Health Expenditures , Humans , Male , Middle Aged

12.

[Multidisciplinary approach to the treatment of chronic heart failure: principles of organization and practical application]. / Mul'tidistsiplinarnyi podkhod k lecheniiu khronicheskoi serdechnoi nedostatochnosti: printsipy organizatsii i prakticheskoe primenenie.

Giliarevskii, S R.

Kardiologiia ; 42(7): 80-7, 2002.

Article Ru | MEDLINE | ID: mdl-12494118

Health Services Administration , Heart Failure/therapy , Interdisciplinary Communication , Patient Care Team , Chronic Disease , Evidence-Based Medicine , Humans

13.

[Effect of therapeutic education of patients with chronic heart failure on quality of life and requirement of rehospitalizations. Results of 12-months randomized study]. / Vliianie terapevticheskogo obucheniia bol'nykh s vyrazhennoi khronicheskoi serdechnoi nedostatochnost'iu na kachestvo ikh zhizni i potrebnost' v povtornykh gospitalizatsiiakh: rezul'taty 12-mesiachnogo randomizirovannogo issledovaniia.

Giliarevskii, S R; Orlov, V A; Khamaganova, L K; Bendeliani, N G; Boeva, O A; Seredenina, E M.

Kardiologiia ; 42(5): 56-61, 2002.

Article Ru | MEDLINE | ID: mdl-12494151

Heart Failure , Patient Education as Topic , Quality of Life , Aged , Data Interpretation, Statistical , Female , Follow-Up Studies , Heart Failure/diagnosis , Heart Failure/mortality , Heart Failure/therapy , Humans , Male , Middle Aged , Patient Readmission , Risk Factors , Surveys and Questionnaires , Time Factors

14.

[Pharmacoeconomic aspects of the treatment of essential hypertension]. / Farmakoékonomicheskie aspekty lecheniia éssentsial'noi gipertonii.

Martynov, A I; Giliarevskii, S R; Ostroumova, O D; Nesterova, M V; Mamaev, V I.

Ter Arkh ; 73(9): 82-8, 2001.

Article Ru | MEDLINE | ID: mdl-11642090

Antihypertensive Agents/economics , Hypertension/economics , Antihypertensive Agents/therapeutic use , Costs and Cost Analysis , Drug Therapy, Combination , Humans , Hypertension/drug therapy

15.

[The use of ramipril in treating patients with chronic heart failure]. / Primenenie ramiprila pri lechenii bol'nykh s khronicheskoi serdechnoi nedostatochnost'iu.

Sinitsina, I I; Orlov, V A; Zakharova, G Iu; Giliarevskii, S R; Ivasenko, L A.

Ter Arkh ; 67(5): 75-7, 1995.

Article Ru | MEDLINE | ID: mdl-7638788

Heart Failure/drug therapy , Ramipril/therapeutic use , Cardiomyopathy, Dilated/complications , Chronic Disease , Digoxin/therapeutic use , Diuretics/therapeutic use , Drug Evaluation , Drug Therapy, Combination , Exercise Tolerance/drug effects , Heart Failure/etiology , Heart Failure/physiopathology , Hemodynamics/drug effects , Humans , Middle Aged , Ramipril/adverse effects , Rheumatic Heart Disease/complications , Time Factors

16.

[Correction of postinfarction remodelling of the heart with angiotensin-converting enzyme inhibitors]. / Korrektsiia postinfarktnogo remodelirovaniia serdtsa ingibitorami angiotenzinprevrashchaiushchego fermenta.

Giliarevskii, S R; Orlov, V A; Gvindzhiliia, T V.

Kardiologiia ; 33(12): 37-47, 1993.

Article Ru | MEDLINE | ID: mdl-8196256

Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Cardiac Output, Low/drug therapy , Cardiac Output, Low/etiology , Myocardial Infarction/complications , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Animals , Cardiac Output, Low/physiopathology , Clinical Trials as Topic , Hemodynamics/drug effects , Humans , Myocardial Infarction/drug therapy , Myocardial Infarction/physiopathology , Myocardial Reperfusion Injury/drug therapy , Time Factors

17.

[Assessment of the quality of life of patients with rheumatic mitral defects: methodological approaches]. / Otsenka kachestva zhizni bol'nykh revmaticheskimi mitral'nymi porokami serdtsa: metodicheskie podkhody.

Giliarevskii, S R; Orlov, V A.

Kardiologiia ; 32(6): 49-53, 1992 Jun.

Article Ru | MEDLINE | ID: mdl-1405295

Mitral Valve Insufficiency/diagnosis , Mitral Valve Stenosis/diagnosis , Rheumatic Heart Disease/diagnosis , Activities of Daily Living , Adolescent , Adult , Female , Humans , Male , Middle Aged , Mitral Valve Insufficiency/psychology , Mitral Valve Stenosis/psychology , Quality of Life , Rheumatic Heart Disease/psychology